admin

In my last piece discussing Inovio (NASDAQ:INO) stock, I mentioned reasons to remain positive on the biotech company despite a sharp pullback recently. But it looks like Inovio’s chances for mounting a comeback are slowly slipping away. Source: Ascannio / Shutterstock.com The markets have spoken. They want something concrete from the biotech company before they can
0 Comments
(L-R) Lloyd Blankfein and David Solomon attend NYSCF Annual Summer Cocktail Reception at Private Residence on July 15, 2016 in Sagaponack, NY. Sean Zanni | Patrick McMullan | Getty Images Goldman Sachs is moving to claw back tens of millions of dollars in compensation it’s paid executives including CEO David Solomon and former CEO Lloyd
0 Comments
Prepared by Tara, Senior Analyst at BAD BEAT Investing CSX Corporation’s (CSX) stock has been chugging along as the company is working to get back on track. While things are definitely improving economically, the company is still facing some headwinds, most notably in its coal volumes, and not from general economic pressures. Rail data certainly
0 Comments
JPMorgan’s Business Complete Banking service Source: JP Morgan JPMorgan Chase is making a play to sell more services to millions of American small business owners, pushing into an area pioneered by fintech firms including Square, PayPal and First Data, CNBC has learned. The bank is rolling out a checking account that is paired with a
0 Comments
For months, income investors justified the investment in AT&T (NYSE:T) as low risk. AT&T stock paid a dividend of about 7% at $30. But in the last two months, selling pressure intensified and it shows no signs of reversing course. Source: Jonathan Weiss/Shutterstock Why is bearish selling picking up the pace for AT&T on the
0 Comments
“Make America Great Again?” If you’re a Biden fan or even if you’re not, the U.S. could be getting ever closer to that reality. And while a chorus of warnings for stocks comes with a new Commander in Chief, these three Democrat-backed, election stocks to buy stand to prosper and are ready for your portfolio
0 Comments
Prescription drug price comparison platform GoodRx (NASDAQ:GDRX) has a noble mission of helping people to locate the medications they need at the best available price. It’s an idea whose time has come, and I’m glad to see that the recent initial public offering (IPO) of GoodRx stock was accompanied by heavy trading volume. Source: II.studio
0 Comments